Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary M Tse

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Archives of Pathology & Laboratory Medicine|July 30, 2016
Immunohistochemical Surrogates for Molecular Classification of Breast Carcinoma: A 2015 UpdatePing Tang, Gary M Tse
Seminars in Diagnostic Pathology|June 19, 2022
Papillary lesions of the breast - review and practical issuesYunbi Ni, Gary M Tse
Human Pathology|May 29, 2025
Best pathology practices for HER2 testing interpretation, including HER2-low and ultralow, in the era of HER2-directed antibody drug conjugates (ADCs), aligned with the 2018 CAP/ASCO HER2 guidelinesMonalyn Marabi, Gary M Tse
Archives of Pathology & Laboratory Medicine|August 17, 2022
Spindle Cell Lesions of the Breast: A Diagnostic AlgorithmYunbi Ni, Gary M Tse
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 3, 2021
Breast cancer with neuroendocrine differentiation: an update based on the latest WHO classificationJulia Y Tsang, Gary M Tse
Histopathology|December 5, 2022
Update on triple-negative breast cancers - highlighting subtyping update and treatment implicationJulia Y Tsang, Gary M Tse
Breast Cancer Research and Treatment|June 8, 2010
Diagnosing breast lesions by fine needle aspiration cytology or core biopsy: which is better?Gary M Tse, Puay-Hoon Tan
Histopathology|January 16, 2016
Pathological criteria and practical issues in papillary lesions of the breast - a reviewYun-Bi Ni, Gary M Tse
Advances in Anatomic Pathology|May 3, 2019
Molecular Classification of Breast CancerJulia Y S Tsang, Gary M Tse
Pathology|August 11, 2020
Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challengeJoshua J X Li, Gary M Tse
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Archives of Pathology & Laboratory Medicine|July 30, 2016
Immunohistochemical Surrogates for Molecular Classification of Breast Carcinoma: A 2015 UpdatePing Tang, Gary M Tse
Seminars in Diagnostic Pathology|June 19, 2022
Papillary lesions of the breast - review and practical issuesYunbi Ni, Gary M Tse
Human Pathology|May 29, 2025
Best pathology practices for HER2 testing interpretation, including HER2-low and ultralow, in the era of HER2-directed antibody drug conjugates (ADCs), aligned with the 2018 CAP/ASCO HER2 guidelinesMonalyn Marabi, Gary M Tse
Archives of Pathology & Laboratory Medicine|August 17, 2022
Spindle Cell Lesions of the Breast: A Diagnostic AlgorithmYunbi Ni, Gary M Tse
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 3, 2021
Breast cancer with neuroendocrine differentiation: an update based on the latest WHO classificationJulia Y Tsang, Gary M Tse
Histopathology|December 5, 2022
Update on triple-negative breast cancers - highlighting subtyping update and treatment implicationJulia Y Tsang, Gary M Tse
Breast Cancer Research and Treatment|June 8, 2010
Diagnosing breast lesions by fine needle aspiration cytology or core biopsy: which is better?Gary M Tse, Puay-Hoon Tan
Histopathology|January 16, 2016
Pathological criteria and practical issues in papillary lesions of the breast - a reviewYun-Bi Ni, Gary M Tse
Advances in Anatomic Pathology|May 3, 2019
Molecular Classification of Breast CancerJulia Y S Tsang, Gary M Tse
Pathology|August 11, 2020
Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challengeJoshua J X Li, Gary M Tse
Pageof 16